Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Lett Appl Microbiol ; 73(5): 579-589, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34338346

RESUMO

The severe side-effects elicited by conventional antibiotic therapy and the recurrence of Bacterial vaginosis-associated bacteria and bacterial resistance have led to the development of novel alternative therapies, among which genital probiotics are widely used. In this study, we aimed to evaluate the antimicrobial activities of Lactobacillus plantarum Lp62 and its supernatant against Gardnerella vaginalis, using both in vitro and in vivo approaches. In vitro assays were used to evaluate the viability of the strain and the antimicrobial activities of the supernatant in different pH ranges. An in vivo assay was performed on female BALB/c mice, wherein the animals were divided into eight groups: four control groups and four treated groups (for curative and preventive therapies). After infecting and treating the mice, the animals were killed to quantify the bacterial load using qPCR, evaluate leucocyte cellular response, determine vaginal cytokine levels and perform cytokine tissue gene expression. Our analyses revealed significant activity of the strain and its supernatant against G. vaginalis. Preliminary in vitro tests showed that the strain grew with equal efficiency in different pH ranges. Meanwhile, the presence of halo and inhibition of pathogen growth established the significant activity of the supernatant against G. vaginalis. We observed that both micro-organisms are resident bacteria of mouse microbiota and that the lactobacilli population growth was affected by G. vaginalis and vice versa. We also observed that the treated groups, with their low bacterial load, absence of leucocyte recruitment, reduced cytokine levels in the vaginal lavage and normalized cytokine gene expression, successfully controlled the infection.


Assuntos
Lactobacillus plantarum , Probióticos , Vaginose Bacteriana , Animais , Feminino , Gardnerella vaginalis , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Vaginose Bacteriana/terapia
2.
Oper Dent ; 38(3): E1-8, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23088189

RESUMO

The aim of this study was to evaluate in vitro the hardness and shrinkage of a pre-cooled or preheated hybrid composite resin cured by a quartz-tungsten-halogen light (QTH) and light-emitting diode (LED) curing units. The temperature on the tip of the devices was also investigated. Specimens of Charisma resin composite were produced with a metal mold kept under 37°C. The syringes were submitted to 4°C, 23°C, and 60°C (n=20) before light-curing, which was carried out with the Optilux 501 VCL and Elipar FreeLight 2 units for 20 seconds. The specimens were kept under 37°C in a high humidity condition and darkness for 48 hours. The Knoop hardness test was carried out with a 50 gram-force (gf) load for 10 seconds, and the measurement of the shrinkage gap was carried out using an optical microscope. The data were subjected to analysis of variance and the Games-Howell test (α=0.05). The mean hardness of the groups were similar, irrespective of the temperatures (p>0.05). For 4°C and 60°C, the top surface light-cured by LED presented significantly reduced shrinkage when compared with the bottom and to both surfaces cured by QTH (p<0.05). It was concluded that the hardness was not affected by pre-cooling or preheating. However, polymerization shrinkage was slightly affected by different pre-polymerization temperatures. The QTH-curing generated greater shrinkage than LED-curing only when the composite was preheated. Different temperatures did not affect the composite hardness and shrinkage when cured by a LED curing unit.


Assuntos
Resinas Compostas/química , Lâmpadas de Polimerização Dentária/classificação , Materiais Dentários/química , Temperatura Baixa , Resinas Compostas/efeitos da radiação , Escuridão , Materiais Dentários/efeitos da radiação , Análise do Estresse Dentário/instrumentação , Dureza , Temperatura Alta , Humanos , Umidade , Cura Luminosa de Adesivos Dentários/instrumentação , Cura Luminosa de Adesivos Dentários/métodos , Teste de Materiais , Polimerização , Estresse Mecânico , Propriedades de Superfície
3.
Am J Trop Med Hyg ; 57(2): 168-71, 1997 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9288810

RESUMO

The prevalence of anti-Leishmania donovani antibodies was investigated in 1,500 Brazilian blood donors and multiply transfused hemodialysis patients. Sera were tested using the fucose-mannose ligand (FML) ELISA, which was shown to have 100% sensitivity and 96% specificity for kala-azar. Among 1,194 volunteer blood donors, seroreactivity was 9%, increasing to 25% in a periurban kala-azar focus. However, higher positivity (37%) was found in multiply transfused hemodialysis patients from Natal, where kala-azar is constantly present in low numbers (endemic), with sporadic outbreaks in localized regions (endemic and epidemic). Risk factors included blood transfusion, which was significantly associated with the presence of anti-Leishmania antibodies (chi2 = 8.567, P < 0.005), but did not include potential exposure to sandfly bites (chi2 = 0.033, P > 0.1). The prevalence significantly decreased to 7% in hemodialysis patients from Rio de Janeiro, where kala-azar is only occasionally seen, and was 0% in patients undergoing continuous ambulatorial peritoneal dialysis. The prospective analysis of 27 FML-seroreactive donors from Natal revealed amastigotes of Leishmania in the bone marrow of one subject while four had clinical complaints, including splenomegaly and hepatosplenomegaly. Our results point to the need for control of blood transfusion as a possible route for transmission of kala-azar in endemic areas.


Assuntos
Anticorpos Antiprotozoários/análise , Leishmania donovani/imunologia , Leishmaniose Visceral/epidemiologia , Animais , Doadores de Sangue , Medula Óssea/parasitologia , Brasil/epidemiologia , Ensaio de Imunoadsorção Enzimática/métodos , Humanos , Leishmaniose Visceral/diagnóstico , Leishmaniose Visceral/imunologia , Fígado/parasitologia , Prevalência , Psychodidae/parasitologia , Diálise Renal/efeitos adversos , Fatores de Risco , Sensibilidade e Especificidade , Estudos Soroepidemiológicos , Baço/parasitologia , Reação Transfusional
4.
Rev. Assoc. Med. Bras. (1992, Impr.) ; Rev. Assoc. Med. Bras. (1992, Impr.);43(1): 4-8, jan.-mar. 1997. ilus, tab, graf
Artigo em Português | LILACS | ID: lil-188390

RESUMO

Objetivo. Identificar correlaçao entre duraçao do tratamento dialítico, gravidade da doença renal cística adquirida (DRCA) medida pelo tamanho dos cistos e seu efeito sobre a correçao espontânea da anemia. Material e Métodos. Foram selecionados dez pacientes, seis do sexo masculino e quatro do feminino, com mais de cinco anos em tratamento dialítico. Nenhum paciente selecionado tinha doença renal policística bilateral como doença primária. A avaliaçao renal foi feita com ulra-sonografia. DRCA foi caracterizada pela presença de quatro ou mais cistos em cada rim. Os maiores cistos foram medidos para efeito de correlaçao. O diagnóstico da anemia foi estabelecido pelo valor do hematócrito e da hemoglobina séricos. Foram analisados, também, uréia, creatinina, albumina, ferro, capacidade total de combinaçao do ferro e o percentual de saturaçao da transferrina séricos. Resultados. Os pacientes estavam adequadamente dialisados (uréia e creatinina séricas = 98,7 + 35mg/dL e 9,7 + 2,7 mg/dL, respectivamente), com bom estado nutricional (albumina sérica = 4,5 + 0,5g/dL), e tinham razoável reserva de ferro (ferro sérico = 80 + 34mg/dL). A prevalência de DRCA foi de 80 por cento. Nao detectamos nenhum sinal ultra-sonográfico de malignidade nesses cistos. Houve correlaçao significante entre tempo de diálise e hematócrito (R = 0,70: p<0,05). O tamanho dos cistos teve correlaçao direta e significante com os valores do hematócrito (R = 0,74; p < 0,05). Conclusoes. Os resultados mostram que a melhora espontânea da anemia observada nos pacientes em diálise crônica se correlaciona de forma significante com a gravidade da doença renal cística adquirida. Isso sugere uma atividade funcional dos cistos renais na produçao de eritropoetina.


Assuntos
Adulto , Feminino , Humanos , Diálise Renal , Doenças Renais Císticas , Anemia , Falência Renal Crônica , Fatores de Tempo , Índice de Gravidade de Doença , Modelos Lineares , Estudos Prospectivos , Eritropoetina/fisiologia , Doenças Renais Císticas , Hematócrito
5.
Rev Assoc Med Bras (1992) ; 43(1): 4-8, 1997.
Artigo em Português | MEDLINE | ID: mdl-9224984

RESUMO

OBJECTIVE: To identify a correlation between dialysis treatment duration and severity of acquired cystic disease of the end-stage kidney measured by cyst sizes; and assess its effect on spontaneous improvement of anemia. MATERIALS AND METHODS: Ten patients, 6 males and 4 females were selected, who have been on hemodialytic treatment for more than 5 years. There was no patient selected with autosomal dominant polycystic kidney disease. The renal evaluation has been made through ultrasonographic studies. Acquired cystic disease of the end-stage kidney was characterized by finding four or more cysts in both kidneys. The largest cysts were measured for correlation effect. The diagnosis of anemia was established by hematocrit and hemoglobin serum values. It has also been analyzed serum urea, creatinine, albumin, iron, total iron-binding capacity and the per cent saturation of serum transferrin were tested. RESULTS: The patients were properly dialysed (serum urea and creatinine = 98.7 +/- 35 mg/dL e 9.7 +/- 2.7 mg/dL, respectively). There were in good nutritional shape (serum albumin = 4.5 +/- 0.5 g/dL) and had normal serum iron level (serum iron = 80 +/- 34 mg/dL). The prevalence of acquired renal cystic disease was 80%. No finding of malignancy has been detected in these cysts. There was a significant correlation between time on dialysis treatment and hematocrit values (R = 0.70; p < 0.05). Cyst sizes had a direct and significant correlation with hematocrit levels (R = 0.74; p < 0.05). CONCLUSION: These results show that spontaneous improvement on anemia seen in patients on chronic dialysis has a significant correlation with the severity of acquired cystic disease of the end-stage kidney. Our data suggest a functional role of acquired kidney cysts on endogenous erythropoietin production.


Assuntos
Anemia/complicações , Doenças Renais Císticas/complicações , Falência Renal Crônica/complicações , Adulto , Eritropoetina/fisiologia , Feminino , Hematócrito , Humanos , Doenças Renais Císticas/diagnóstico por imagem , Falência Renal Crônica/terapia , Modelos Lineares , Masculino , Estudos Prospectivos , Diálise Renal , Índice de Gravidade de Doença , Fatores de Tempo , Ultrassonografia
6.
Hypertension ; 19(2 Suppl): II279-83, 1992 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-1735593

RESUMO

To study if the severity of hypertension could be associated with disturbances of the autoregulation of renal blood flow and glomerular filtration, we compared the renal hemodynamic and functional responses to acute blood pressure reductions of a group of patients with moderate essential hypertension (n = 10) with those of a group of patients with severe hypertension (n = 10). Blood pressure was reduced to normal levels by a stepwise infusion of sodium nitroprusside, and effective renal blood flow (by 131I-hippuran), glomerular filtration rate (by endogenous creatinine clearance), and filtration fraction were determined. After acute blood pressure normalization, effective renal blood flow and glomerular filtration rate were significantly reduced in patients with severe hypertension (-41.6 +/- 8.3% and -44.7 +/- 6.8%, respectively; p less than 0.01 for both) but not in those with moderate hypertension (+4.9 +/- 9.1% and +6.2 +/- 13.3%, respectively; NS). Filtration fraction remained unchanged in both groups. These results show that severe but not moderate essential hypertensive patients have a displacement to the right of the lower limit of the renal autoregulation curve due to impaired vasodilation to maintain adequate renal blood flow during acute reductions of blood pressure. This impairment may be due to anatomic or functional defects of preglomerular vessels, or to both. Furthermore, the inability to maintain adequate glomerular filtration in these circumstances shows that patients with severe hypertension also have an impaired ability to adjust postglomerular vasomotor tone in the face of reductions in glomerular blood flow.


Assuntos
Hipertensão/fisiopatologia , Rim/fisiopatologia , Adolescente , Adulto , Pressão Sanguínea/efeitos dos fármacos , Feminino , Taxa de Filtração Glomerular/efeitos dos fármacos , Hemodinâmica , Homeostase , Humanos , Masculino , Pessoa de Meia-Idade , Nitroprussiato/farmacologia , Fluxo Sanguíneo Regional/efeitos dos fármacos , Índice de Gravidade de Doença
7.
J Hypertens Suppl ; 7(6): S288-9, 1989 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2534415

RESUMO

In view of the possibility that cardiac hypertrophy may be reversed by isradipine, we studied the effect of two different doses of isradipine (1.0 and 7.0 mg/kg per day) on relative cardiac weight in the rat. These doses have proved equipotent in lowering the blood pressure of the two-kidney, one clip model of hypertension. Untreated hypertensive rats had significantly greater cardiac weights than the untreated controls (3.16 +/- 0.06 versus 2.31 +/- 0.05 mg/g, P less than 0.001). Hypertrophy was still present in the group treated with isradipine at 1.0 mg/kg per day (3.17 +/- 0.07 versus 2.30 +/- 0.03 mg/g; P less than 0.001) but not with 7.0 mg/kg per day (2.55 +/- 0.17 versus 2.37 +/- 0.11 mg/g; NS). Functional studies revealed that reversal of cardiac hypertrophy did not affect cardiac performance compared with the ventricles with increased mass. These results suggest that reversal of left ventricular hypertrophy with isradipine is dependent on complex mechanisms, possibly unrelated to the unloading of the heart.


Assuntos
Anti-Hipertensivos/uso terapêutico , Bloqueadores dos Canais de Cálcio/uso terapêutico , Cardiomegalia/tratamento farmacológico , Coração/efeitos dos fármacos , Hipertensão/tratamento farmacológico , Piridinas/uso terapêutico , Animais , Cardiomegalia/etiologia , Cardiomegalia/fisiopatologia , Avaliação Pré-Clínica de Medicamentos , Coração/fisiopatologia , Ventrículos do Coração/efeitos dos fármacos , Ventrículos do Coração/fisiopatologia , Hemodinâmica/efeitos dos fármacos , Hemodinâmica/fisiologia , Hipertensão/complicações , Hipertensão/fisiopatologia , Isradipino , Masculino , Ratos , Ratos Endogâmicos , Indução de Remissão
8.
Hypertension ; 11(2 Pt 2): I89-92, 1988 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2964407

RESUMO

Reversal of cardiac hypertrophy has been obtained by treatment with some antihypertensive drugs but has not been achieved consistently with beta blockers. To investigate whether this difference might be explained by the distinct hemodynamic actions of the drugs, we studied the effects of propranolol and pindolol, beta blockers with distinct modes of action, on cardiac hypertrophy of hypertensive male Wistar rats, two-kidney, one clip (2K1C) Goldblatt model (n = 33) and sham-operated control rats (n = 34). We also assessed the effects of such therapies on the ventricular pumping ability during open-chest, transient aortic occlusion. Four weeks after surgery, propranolol (5 mg/kg/day p.o.) was given to hypertensive (n = 8) and control rats (n = 11); pindolol was also given orally (1 mg/kg/day) to similar groups (n = 7 and n = 5, respectively). Untreated animals served as controls for both groups. Cardiac hypertrophy developed with hypertension in the untreated rats of the propranolol (3.38 +/- 0.18 vs 2.60 +/- 0.08 mg/g; p less than 0.01) and pindolol groups (3.93 +/- 0.21 vs 2.40 +/- 0.03 mg/g; p less than 0.001). Treatment reversed cardiac hypertrophy in the pindolol-treated (3.01 +/- 0.19 vs 3.93 +/- 0.21 mg/g; p less than 0.001, NS) but not in the propranolol-treated rats (3.24 +/- 0.18 vs 3.38 +/- 0.21 mg/g, NS). The maximal pressure that developed during aortic occlusion in the propranolol group was similar to that observed in the pindolol group. These results indicate that cardiac hypertrophy is reversed by pindolol but not by propranolol, and that this reversal does not interfere with left ventricular pumping ability.


Assuntos
Cardiomegalia/tratamento farmacológico , Hipertensão Renovascular/complicações , Pindolol/uso terapêutico , Propranolol/uso terapêutico , Animais , Pressão Sanguínea/efeitos dos fármacos , Cardiomegalia/etiologia , Masculino , Contração Miocárdica/efeitos dos fármacos , Ratos , Ratos Endogâmicos
9.
J Hypertens Suppl ; 5(5): S403-6, 1987 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2965226

RESUMO

Left ventricular hypertrophy can be reversed by treatment of hypertension with captopril but the consequences of this regression are not yet fully described. We studied the maximal capacity of the hypertrophied and hypertrophy-reversed ventricle to generate pressure during transient total occlusion of the aorta, and also the left ventricular end-diastolic pressure required to meet this maximal effort. Two-kidney, one clip Goldblatt (renal hypertensive rats; RHR) hypertension was induced in 17 Wistar rats, eight of which were treated with captopril (RHR-C: 50 mg/kg given orally) from the fourth to the eighth week. Sham-operated controls (SC) remained untreated, or were treated with similar doses of captopril (SC-C). Significantly lower heart weights were found in RHR-C than in RHR (2.88 +/- 0.15 versus 2.38 +/- 0.04; P less than 0.001). During transient total occlusion of the aorta, the maximal intraventricular pressure developed in RHR-C was not significantly different from that in RHR, but left ventricular end-diastolic pressure was significantly less in RHR-C than in RHR (21.4 +/- 2.2 versus 34.3 +/- 3.8; P less than 0.01). The analysis of pressure-volume characteristics of the hypertrophied left ventricles and those in which hypertrophy was reversed revealed similar compliances between these two groups. Our data suggest that there was a mechanical improvement in the heart function after reversal of left ventricular hypertrophy.


Assuntos
Captopril/uso terapêutico , Cardiomegalia/tratamento farmacológico , Hipertensão/complicações , Contração Miocárdica/efeitos dos fármacos , Animais , Volume Sanguíneo , Cardiomegalia/etiologia , Cardiomegalia/fisiopatologia , Masculino , Pressão , Ratos , Ratos Endogâmicos
13.
Arq Inst Biol (Sao Paulo) ; 44(4): 225-8, 1977.
Artigo em Português | MEDLINE | ID: mdl-614830

RESUMO

This paper describes a potentiographic complexometric technique developed for determining mercury in mercurial pesticides. It is precise, accurate, specific and rapid. It is based on using Titriplex III, U.05M measuring Ipol of mV.


Assuntos
Compostos Organomercúricos/análise , Praguicidas/análise , Potenciometria/métodos
14.
Arq Inst Biol (Sao Paulo) ; 43(3-4): 89-91, 1976.
Artigo em Português | MEDLINE | ID: mdl-1031592

RESUMO

This paper describes a potentiographic technique developed for determining nitrocompound pesticides. The statistical analysis of the results showed that it is precise and accurate. Rapidity is another important characteristic of the developed potentiographic technique. It is not specific and for that in some cases a column chromatographic cleanup is necessary.


Assuntos
Nitrocompostos/análise , Praguicidas/análise , Potenciometria/métodos
15.
Arq Inst Biol (Sao Paulo) ; 42: 189-92, 1975.
Artigo em Português | MEDLINE | ID: mdl-1236048

RESUMO

This paper deals with a description of a potentiographic complexometric technique developed for determining copper in cupric fungicides. It is precise, accurate and specific in presence of zinc and manganese (iron and aluminium should be separated). Its great advantage in comparison with the classical method is the quickness.


Assuntos
Cobre/análise , Fungicidas Industriais/análise , Potenciometria/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA